A 51-year-old woman with a past medical history of type II diabetes mellitus and dyslipidemia presented to the Dermatology Department with pain, swelling, and crusting of the lips. This was accompanied by anal pain, odynophagia, and weight loss of 20 kg since the onset of symptoms. Previous evaluations by Head and Neck Surgery, Allergy, and Infectious Diseases Departments included lip biopsy, viral and bacterial cultures, and treatment with topical antifungals, an oral antiviral, topical and oral antibiotics, and topical steroids. The biopsy and culture studies did not reveal the etiology of her condition, and the treatments did not improve her symptoms.One year after onset of her mucosal lesions, the patient developed an abdominal eruption consisting of several tense vesicles and bullae on an erythematous base (Figure 1). She also had lip edema and crusting, oral erosions and ulcerations, and an anal fissure. Histologic examination revealed suprabasal acantholysis (Figure 2), the histologic hallmark of Pemphigus vulgaris (PV) that is essential for diagnosis.1 Furthermore, direct immunofluorescence showed intercellular staining with immunoglobulin G (IgG) and complement test C3, which was also consistent with PV.After biopsy, the patient was empirically started on methylprednisolone, 48 mg daily. After confirmation of her diagnosis, the patient was also started on mycophenolate mofetil, 500 mg twice daily. The methylprednisolone was later switched to prednisone, 80 mg daily, because of gastrointestinal intolerance. Owing to minimal response after 2 months of therapy, the patient received 2 rituximab infusions of 1000 mg, 2 weeks apart. There was noticeable improvement within 2 weeks of her first dose of rituximab.
DISCUSSIONPV is an autoimmune disease with the average age of onset between 40 and 60 years of age. It is characterized by involvement of the oral mucosa, such as painful oral erosions that often precede painful, cutaneous flaccid vesicles and bullae.2 Involvement of the oral mucosa is usually accompanied by severe pain that can lead to weight loss and malnutrition. Although it is a rare disease, with incidence rates between 0.1 and 0.5 per 100,000 people per year, PV has the potential for lifethreatening complications, and treatment is always indicated at the time of disease onset.3 PV can be further subdivided into mucosal dominant type, presenting with mucosal lesions and minimal skin involvement; and mucocutaneous type, which presents with skin blisters and erosions along with mucous membrane lesions. IgG antibodies against desmoglein (Dsg) 1 and Dsg 3, cadherin-type cell-to-cell adhesion molecules in desmosomes, are believed to play a role in inducing vesicle and bullae formation in PV. 4 The dysfunction in Dsg 1 and Dsg 3 results in the loss of cell-to-cell adhesion in skin membranes and mucous membranes, respectively.
ABSTRACTWe report a case of a 51-year-old woman with a history of type II diabetes mellitus and dyslipidemia presenting with pain, swelling, and crusting of the lips. One year aft...